FDA Inspection
Transpire Bio Inc.Transpire Bio Inc. – FDA Inspection, Oct 1, 2025
Record Details
This FDA Inspection record concerns Transpire Bio Inc., with an inspection on October 1, 2025, issued by the Florida District Office, covering human drugs.
View Company Profile
ID · 56f779d3-8c38-4b9e-9d6c-f5880c304c40
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1285042
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
FDA Citations
3- 21 CFR 211.182Specific information required in individual logs
- 21 CFR 211.192Quality control unit review of records
- 21 CFR 211.82(b)Quarantine Storage of Components
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Transpire Bio Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2025 | Not classified | Florida District Office |
Other documents for Transpire Bio Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.